What should be reviewed before initiating fibrinolytic therapy?

Before initiating fibrinolytic therapy, it is crucial to review the patient's medical history for contraindications. Fibrinolytic therapy is used to dissolve blood clots that can cause conditions such as myocardial infarction or stroke, but it also carries significant risks. Conditions that may contraindicate the therapy include recent surgery, hemorrhagic stroke, active bleeding, or certain chronic conditions that could increase the risk of bleeding. By thoroughly evaluating the patient’s medical history, healthcare providers can ensure that the benefits of fibrinolytic therapy outweigh the risks and make informed decisions about the patient's treatment plan.

Examining aspects such as social history or diet history does not directly impact the immediate safety or efficacy of fibrinolytic therapy, while allergy history, although important in general, is less critical than understanding potential health conditions that may lead to complications during this specific treatment.